Alkem Labs sets up Saudi Arabian subsidiary

Alkem Laboratories has incorporated subsidiary in the form of Joint Venture (JV) in the name of ‘Alkem Pharma Company’, Limited Liability Company in the Kingdom of Saudi Arabia on November 8, 2026. The Subsidiary has been incorporated for manufacture, import, marketing and distribution of pharmaceutical and/or nutraceutical products within the Kingdom of Saudi Arabia. The investment in the Subsidiary is a strategic investment undertaken by the company with the objective of expanding the company’s business and market reach to the Kingdom of Saudi Arabia. Outlook: Alkem continues its Middle East expansion after setting up a Dubai-based registration office and export hub earlier in 2026. The creation of this new Saudi corporate entity now gives Alkem direct, fully managed access to the Gulf region's premier pharmaceutical market. Disclosure : I do not hold any position in the mentioned stock. This is only for educational purpose. ALKEM